AstraZeneca To Resume COVID-19 Vaccine Study After Pause Caused By Serious Symptoms In Patient

AstraZeneca To Resume COVID-19 Vaccine Study After Pause Caused By Serious Symptoms In Patient


AstraZeneca has resumed clinical trials for its coronavirus vaccine in the United Kingdom after studies globally were placed on hold due to a standard review process that revealed one patient had severe negative symptoms last week, Reuter’s reported.

AstraZeneca’s vaccine, named AZD1222, is among nine coronavirus vaccines in either Phase 2 or Phase 3 trials, and is regarded as one of the most promising candidates for a COVID-19 cure, according to Reuters. That reputation was put in jeopardy when the review uncovered serious negative symptoms in a single patient in the U.K.

Symptoms that require hospitalization or are life-threatening are classified as serious adverse reactions.

Trending: Joe Biden Attempts to Demonstrate His Reading and Math Skills at Michigan Rally

A laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 (Photo by Vincenzo PINTO / AFP)

A laboratory technician supervises capped vials during filling and packaging tests for the large-scale production and supply of the University of Oxfords COVID-19 vaccine candidate, AZD1222, conducted on a high-performance aseptic vial filling line on September 11, 2020 (Photo by Vincenzo

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!